At a Glance
| 3-MeO-PCMo | Dextromethorphan | |
|---|---|---|
| Class | Dissociatives | Dissociatives |
| Common Dose (oral) | 200–300 mg | 200–400 mg |
| Total Duration | 3–5 hrs | 4.5–10 hrs |
| Routes | oral | oral |
| Effects | 36 documented | 110 documented |
3-MeO-PCMo, a Dissociatives, and Dextromethorphan, a Dissociatives, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Dissociativess, meaning they share a common pharmacological foundation. They share 35 documented effects in common, with 1 effects unique to 3-MeO-PCMo and 75 unique to Dextromethorphan. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 3-MeO-PCMo | Dextromethorphan | |
|---|---|---|
| Class | Dissociatives | Dissociatives |
| Common Dose (oral) | 200–300 mg | 200–400 mg |
| Total Duration | 3–5 hrs | 4.5–10 hrs |
| Routes | oral | oral |
| Effects | 36 documented | 110 documented |
| Interaction |
| Caution |
| Level | 3-MeO-PCMo | Dextromethorphan |
|---|---|---|
| Threshold | 50 mg | 75 mg |
| Light | 100–200 mg | 100–200 mg |
| Common | 200–300 mg | 200–400 mg |
| Strong | 300–400 mg | 400–700 mg |
| Heavy | 400 mg | 700 mg |
3-MeO-PCMo
Dextromethorphan
Compounding dissociative effects can cause confusion, mania, and loss of motor control